Abstract
CERTAIN analogues of adenosine have been found to act both in vivo as vasodilators and in vitro as inhibitors of ADP-mediated platelet aggregation, and Born et al.1 suggested that this dual activity may preclude the potential usefulness of adenosine analogues as antithrombotic agents. Work in this institute with 2-substituted adenosine analogues showed that, although they have both vasodilatory and platelet aggregation inhibitory properties, some analogues, for example, 2-methoxyadenosine and 2-trifluoromethyladenosine, were considerably less potent as inhibitors of platelet aggregation than as vasodilators (Table 1). These observations suggested that it may be possible in suitable analogues to separate the two effects. 2-Methylthioadenosine-5′-phosphate (patent application filed) was found to be a potent inhibitor of ADP-mediated platelet aggregation but to have no discernible effects on the cardiovascular system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Born, G. V. R., Haslam, R. J., Goldman, M., and Rowe, R. D., Nature, 205, 678 (1965).
Tener, G. M., J. Amer. Chem. Soc., 83, 159 (1961).
Maguire, M. H., and Michal, F., Nature, 217, 571 (1968).
Gough, G., Maguire, M. H., and Michal, F., J. Med. Chem. (in the press).
Clayton, S., Born, G. V. R., and Cross, M. J., Nature, 200, 138 (1963).
Schaeffer, H. J., and Thomas, H. J., J. Amer. Chem. Soc., 80, 3738 (1958).
Gough, G., and Maguire, M. H., J. Med. Chem., 8, 866 (1965).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MICHAL, F., MAGUIRE, M. & GOUGH, G. 2-Methylthioadenosine-5′-phosphate: a Specific Inhibitor of Platelet Aggregation. Nature 222, 1073–1074 (1969). https://doi.org/10.1038/2221073a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/2221073a0
This article is cited by
-
The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range
Naunyn-Schmiedeberg's Archives of Pharmacology (2005)
-
Ecto-ATPase
Molecular and Cellular Biochemistry (1981)
-
Effects of the 3′, 5′-cyclic phosphates of 2-methylthioadenosine, 2-chloroadenosine and adenosine on platelet aggregation
Experientia (1974)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.